![Polycythemia vera / Essential thrombocytosis / Fibrosis / Medicine / Myeloproliferative disease / Myelofibrosis Polycythemia vera / Essential thrombocytosis / Fibrosis / Medicine / Myeloproliferative disease / Myelofibrosis](https://www.pdfsearch.io/img/a4d21164024a2142e2bf1bab3912113e.jpg) Date: 2014-06-13 01:07:42Polycythemia vera Essential thrombocytosis Fibrosis Medicine Myeloproliferative disease Myelofibrosis | | Phase 2 Trial of PRM-151, an Anti-Fibrotic Agent, in Patients with Myelofibrosis: Stage 1 Results S. Verstovsek1, R. Mesa2, L. Foltz3, V. Gupta4, J. Mascarenhas5, E. Ritchie6, R. Hoffman5, R. Silver6, W. J. Hong8, M. KreAdd to Reading ListSource URL: www.promedior.comDownload Document from Source Website File Size: 1,74 MBShare Document on Facebook
|